GlassScriptPhysician profile
Matthew Enna
NPI 1396797809
$2,067.32
in general payments reported to CMS, 2019-2025
9 companies · $590 in 2025
The $590 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171 · 2021: $176 · 2022: $16.18 · 2023: $396 · 2024: $718 · 2025: $590.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,704.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,704.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,399.92 | 2023-2025 | N/A, Cap-Fix, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Siemens Medical Solutions USA, INC. | $238.65 | 2021-2023 | Magnetom Aera |
| Stryker Corporation | $237.19 | 2019-2021 | |
| Arthrex, INC. | $80.12 | 2023 | Arthrex |
| Zimmer Biomet Holdings, INC. | $32.58 | 2025 | Juggerknotless Soft Anchor |
| Endo USA, INC. | $25.49 | 2024 | Xiaflex |
| Endo Pharmaceuticals INC. | $21.13 | 2019 | |
| Bioventus LLC | $16.18 | 2022 | |
| Globus Medical, INC. | $16.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Enna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.